Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens
暂无分享,去创建一个
Sten Nilsson | Lars Egevad | Jonathan I. Epstein | Gregor Mikuz | Rodolfo Montironi | Peter A. Humphrey | John R. Srigley | Thomas M. Wheeler | P. Humphrey | J. Srigley | L. Egevad | J. Epstein | M. Amin | R. Montironi | T. Wheeler | W. Sakr | S. Nilsson | D. Newling | G. Mikuz | Wael Sakr | Mahul Amin | Liliane Boccon-Gibod | Don Newling | L. Boccon‐Gibod
[1] L. Sobin,et al. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. , 1999, Cancer.
[2] B. Trock,et al. Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer? , 2001, Urology.
[3] D. Wood,et al. Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results. , 2002, The Journal of urology.
[4] A. Partin,et al. Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy , 2000, Cancer.
[5] T. Stamey,et al. Assessment of morphometric measurements of prostate carcinoma volume , 2000, Cancer.
[6] D. Bostwick,et al. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. , 1996, The Journal of urology.
[7] H. Frierson,et al. Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate. , 2000, Urology.
[8] A. Hoznek,et al. Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors. , 2003, European urology.
[9] M. Kattan,et al. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. , 2003, Cancer research.
[10] T. Stamey,et al. Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. , 1998, The Journal of urology.
[11] Steven Piantadosi,et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. , 2003, The Journal of urology.
[12] L. Rice,et al. Prostatectomy tissue for research: balancing patient care and discovery. , 1998, American Journal of Clinical Pathology.
[13] A. Partin,et al. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. , 1996, The American journal of surgical pathology.
[14] R W Veltri,et al. Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei. , 1996, Urology.
[15] A W Partin,et al. Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy. , 2000, Urology.
[16] N. Bruchovsky,et al. DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage gleason grade 4 and 5, and lymph node metastases , 1990, Cancer.
[17] L. Layfield,et al. Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate. , 1988, British journal of urology.
[18] Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance , 2003, Virchows Archiv.
[19] T. Stamey,et al. Pathologic parameters and flow cytometric ploidy analysis in predicting recurrence in carcinoma of the prostate. , 1993, European urology.
[20] J. Ross,et al. Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Bostwick Dg,et al. Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer. , 1999 .
[22] M. Becich,et al. Incidence and prognostic significance of lymphatic and vascular invasion in radical prostatectomy specimens , 1989, The Prostate.
[23] T. Stamey,et al. Biological determinants of cancer progression in men with prostate cancer. , 1999, JAMA.
[24] C. Öbek,et al. Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis. , 1999, Urology.
[25] H. G. van der Poel,et al. Intratumoral nuclear morphologic heterogeneity in prostate cancer. , 1997, Urology.
[26] M. Banerjee,et al. Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer. , 1998, The Journal of urology.
[27] E. Ruijter,et al. Processing Radical Prostatectomy Specimens: A Comprehensive and Standardized Protocol , 1998 .
[28] M. Kattan,et al. Prognostic significance of positive surgical margins in radical prostatectomy specimens. , 1995, The Journal of urology.
[29] W. Catalona,et al. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. , 1998, The Journal of urology.
[30] M. Kattan,et al. Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] T. Tsuzuki,et al. The Prognostic Significance of Tertiary Gleason Pattern 5 in Radical Prostatectomy Specimens , 2004, The American journal of surgical pathology.
[32] S. Loening,et al. Positive margins after laparoscopic radical prostatectomy: a prospective study of 100 cases performed by 4 different surgeons. , 2003, European urology.
[33] P. Humphrey,et al. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. , 2004, The Journal of urology.
[34] M. Soloway,et al. Visual estimate of percent of carcinoma predicts recurrence after radical prostatectomy. , 2003, Journal of Urology.
[35] L. Egevad,et al. A New Method for Handling Radical Prostatectomies Enabling Fresh Tissue Harvesting, Whole Mount Sections, and Landmarks for Alignment of Sections , 1998 .
[36] M. Cohen,et al. Prognostic implications of extracapsular extension of lymph node metastases in prostate cancer. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[37] M. Kattan,et al. Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? , 1997, The Journal of urology.
[38] D. Bostwick,et al. Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer. , 2000, The Journal of urology.
[39] P. Walsh,et al. Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy. , 1994, The Journal of urology.
[40] P. Lipponen,et al. Nuclear morphometry is of independent prognostic value only in T1 prostatic adenocarcinomas , 1995, The Prostate.
[41] H. Frierson,et al. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate. , 1997, The Journal of urology.
[42] A. Haese*,et al. Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy. , 1998, Urology.
[43] R. Williams,et al. Incidence of surgical margin involvement in various forms of radical prostatectomy. , 1990, Urology.
[44] M. Blute,et al. Long-term outcome in patients with pTxN+ adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation. , 1998, The Journal of urology.
[45] W. Hop,et al. Tumour control according to pathological variables in patients treated by radical prostatectomy for clinically localized carcinoma of the prostate. , 1997, British journal of urology.
[46] L. Salomon,et al. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression. , 2003, Urology.
[47] N. Smith,et al. Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate. , 1997, The Journal of urology.
[48] F. Schröder,et al. Positive margins after radical prostatectomy: correlation with local recurrence and distant progression. , 1993, British journal of urology.
[49] Michael W Kattan,et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. , 2002, The Journal of urology.
[50] J. Hugosson,et al. Neuroendocrine differentiation is not prognostic of failure after radical prostatectomy but correlates with tumor volume. , 2000, Urology.
[51] R W Veltri,et al. Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression. , 1994, Journal of cellular biochemistry. Supplement.
[52] Markus Graefen,et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer - A multi-institutional update , 2004, Aktuelle Urologie.
[53] L. Layfield,et al. Proliferative index determination in prostatic carcinoma tissue: is there any additional prognostic value greater than that of Gleason score, ploidy and pathological stage? , 1997, The Journal of urology.
[54] D. Bostwick,et al. Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[55] E. Jones,et al. Resection margin status in radical retropubic prostatectomy specimens: relationship to type of operation, tumor size, tumor grade and local tumor extension. , 1990, The Journal of urology.
[56] A. Renshaw,et al. Maximum diameter of prostatic carcinoma is a simple, inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens. Validation in a cohort of 434 patients. , 1999, American journal of clinical pathology.
[57] E. Higashihara,et al. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer. , 2000, The Journal of urology.
[58] C. Pan,et al. Comparative analysis of sampling methods for grossing radical prostatectomy specimens performed for nonpalpable (stage T1c) prostatic adenocarcinoma. , 2001, Human pathology.
[59] J. Epstein,et al. Methods of radical prostatectomy specimen processing: a novel technique for harvesting fresh prostate cancer tissue and review of processing techniques. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[60] D. Wood,et al. Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. The Lupron Depot Neoadjuvant Prostate Cancer Study Group. , 1995, The Journal of urology.
[61] R T Vollmer,et al. Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[62] D. Bostwick,et al. Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis. , 1998, Urology.
[63] P. Humphrey,et al. Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy , 2000, Cancer.
[64] C. Sheehan,et al. Morphologic and Molecular Prognostic Markers in Prostate Cancer , 2002, Advances in anatomic pathology.
[65] C. Abbou,et al. Prognostic Consequences of the Location of Positive Surgical Margins in Organ-Confined Prostate Cancer , 2003, Urologia Internationalis.
[66] P. Casale,et al. DNA ploidy, Gleason score, pathological stage and serum PSA levels as predictors of disease-free survival in C-D1 prostatic cancer patients submitted to radical retropubic prostatectomy. , 1996, European urology.
[67] R. Jenkins,et al. Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radical prostatectomy. , 1999, Mayo Clinic proceedings.
[68] H. Frierson,et al. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy. , 1999, The Journal of urology.
[69] A. Cnaan,et al. Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma. , 1998, American journal of clinical pathology.
[70] M. Wirth,et al. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy. , 1991, European urology.
[71] M. Kattan,et al. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[72] A. Partin,et al. Pathologic findings in clinical stage A2 prostate cancer. Relation of tumor volume, grade, and location to pathologic stage , 1990, Cancer.
[73] J. Melamed,et al. Analysis of apical soft tissue margins during radical retropubic prostatectomy. , 2001, The Journal of urology.
[74] Hartwig Huland,et al. Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy? , 2003, Urology.
[75] M. Kattan,et al. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] P. Walsh,et al. Radical prostatectomy with preservation of sexual function: pathological findings in the first 100 cases. , 1985, The Journal of urology.
[77] T. Stamey,et al. Positive surgical margins at radical prostatectomy: importance of the apical dissection. , 1990, The Journal of urology.
[78] P. Tamboli,et al. Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53. , 1996, Urology.
[79] Pierre Validire,et al. Intraoperative frozen section analysis during nerve sparing laparoscopic radical prostatectomy: feasibility study. , 2003, The Journal of urology.
[80] L. Lacombe,et al. Expression of p21 predicts PSA failure in locally advanced prostate cancer treated by prostatectomy. , 1999, International journal of cancer.
[81] H. Frierson,et al. Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate , 1997, Cancer.
[82] M. Loda,et al. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. , 1998, The Journal of urology.
[83] A. Partin,et al. Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. , 2000, Urology.
[84] Galina Pizov,et al. Correlation of pathologic findings with progression after radical retropubic prostatectomy , 1993, Cancer.
[85] H. Korman,et al. A centralized comparison of radical perineal and retropubic prostatectomy specimens: is there a difference according to the surgical approach? , 2002, The Journal of urology.
[86] M. Banerjee,et al. Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival. , 2000, Urology.
[87] M. Soloway,et al. Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis. , 1996, Urology.
[88] P. Scardino,et al. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? , 1994, The Journal of urology.
[89] M. Kattan,et al. Incidence, Location, and Significance of Periprostatic and Periseminal Vesicle Lymph Nodes in Prostate Cancer , 2001, The American journal of surgical pathology.
[90] C. Abbou,et al. Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer. , 2003, Urology.
[91] M. Kattan,et al. Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor. , 2002, The Journal of urology.
[92] M. Kattan,et al. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. , 1998, Human pathology.
[93] J. Epstein,et al. Evaluation of Radical Prostatectomy Specimens: A Comparative Analysis of Sampling Methods , 1992, The American journal of surgical pathology.
[94] R. B. Smith,et al. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. , 1994, The Journal of urology.
[95] Sam S. Chang,et al. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors. , 2002, The Journal of urology.
[96] C. Pan,et al. The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. , 2000, The American journal of surgical pathology.
[97] M. Kattan,et al. Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology. , 1999, The Journal of urology.
[98] M. Cohen,et al. Sampling of radical prostatectomy specimens. How much is adequate? , 1994, American journal of clinical pathology.
[99] Robert W Veltri,et al. Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy , 2003, Cancer.
[100] J. Serth,et al. Expression of E-cadherin in primary prostate cancer: correlation with clinical features. , 1998, British journal of urology.
[101] D. Bostwick,et al. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery. , 1999, The Journal of urology.
[102] P. Walsh,et al. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). , 1994, The Journal of urology.
[103] M. Litwin,et al. Intraoperative frozen section monitoring of nerve sparing radical retropubic prostatectomy. , 1999, The Journal of urology.
[104] Daniel S. Miller,et al. Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.
[105] R W Veltri,et al. Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy. , 1999, Urology.
[106] J. Endrizzi,et al. The relationship between early biochemical failure and perineural invasion in pathological T2 prostate cancer , 2000, BJU international.
[107] A. Partin,et al. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in gleason sum 5 to 7 adenocarcinoma of the prostate , 1997, Cancer.
[108] P. Carroll,et al. Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomy. , 2002, Urology.
[109] David J. Grignon,et al. The Prostatic Capsule: Does It Exist? Its Importance in the Staging and Treatment of Prostatic Carcinoma , 1989, The American journal of surgical pathology.
[110] A. Haese*,et al. Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer. , 2002, European urology.
[111] B. Guillonneau,et al. Prognostic Significance of Seminal Vesicle Invasion on the Radical Prostatectomy Specimen , 1998, European Urology.
[112] P. Walsh,et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.
[113] M. Rubin,et al. Is Microvascular Invasion on Radical Prostatectomy Specimens a Useful Predictor of PSA Recurrence for Prostate Cancer Patients? , 2000, European Urology.
[114] Y. Collan,et al. Prognostic factors in prostate cancer , 2006, Diagnostic pathology.
[115] V. Speights,et al. Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression , 1994, Cancer.
[116] T. H. van der Kwast,et al. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer. , 2000, The Journal of urology.
[117] M. Soloway,et al. Failure after radical prostatectomy. , 2003, Urology.
[118] M. Kattan,et al. Lymphovascular invasion as a predictor of disease progression in prostate cancer. , 2000, The American journal of surgical pathology.
[119] H. Moch,et al. Ki67 LABELLING INDEX: AN INDEPENDENT PREDICTOR OF PROGRESSION IN PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY , 1996, The Journal of pathology.
[120] J. Goméz,et al. Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study. , 1996, The American journal of surgical pathology.
[121] L. True. Surgical pathology examination of the prostate gland. Practice survey by American society of clinical pathologists. , 1994, American journal of clinical pathology.
[122] G Vallancien,et al. Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris Institute. , 2003, The Journal of urology.
[123] W. Catalona,et al. Nerve-sparing radical prostatectomy: extraprostatic tumor extension and preservation of erectile function. , 1985, The Journal of urology.
[124] J. Oesterling,et al. Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens. , 1986, The Journal of urology.
[125] J. Cheville,et al. Dedifferentiation in the metastatic progression of prostate carcinoma , 1999, Cancer.
[126] P. Rubin,et al. Correlation of prostate‐specific acid phosphatase and prostate‐specific antigen immunocytochemistry with survival in prostate carcinoma , 1989, Cancer.
[127] Victor Reuter,et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. , 2003, The Journal of urology.
[128] D. Bostwick. Grading prostate cancer. , 1994, American journal of clinical pathology.
[129] J. Serth,et al. Article no. bjoc.1999.0806 , 2022 .
[130] H. Levin,et al. Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[131] W. Isaacs,et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. , 1994, Cancer research.
[132] D. Paulson,et al. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence. , 1988, The Journal of urology.
[133] A. Renshaw,et al. An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapy. , 1996, Urology.
[134] A W Partin,et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.
[135] K. Fujikawa,et al. The role of volume‐weighted mean nuclear volume in predicting disease outcome in patients with prostate cancer treated with radical prostatectomy , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[136] D. Bostwick,et al. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma , 1999, Cancer.
[137] A. Neugut,et al. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. , 1999, Urology.
[138] A W Partin,et al. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. , 2001, The Journal of urology.
[139] P. Walsh,et al. Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987. , 1990, The Journal of urology.
[140] T. H. van der Kwast,et al. The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long‐term follow‐up study with patients treated by radical prostatectomy , 1995, International journal of cancer.
[141] T. Wheeler,et al. Fresh tissue harvest for research from prostatectomy specimens , 1994, The Prostate.
[142] H. Levin,et al. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. , 1996, Urology.
[143] P. Walsh,et al. Prospective evaluation of men with stage T1C adenocarcinoma of the prostate. , 1997, The Journal of urology.
[144] A. D'Amico,et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. , 1995, The Journal of urology.
[145] S. Loening,et al. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer , 2000, The Prostate.
[146] M. Kattan,et al. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. , 2001, Human pathology.
[147] T. Tsuzuki,et al. Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression. , 2004, Urology.
[148] P. Carroll,et al. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. , 1996, Urology.
[149] N. Olson,et al. Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. , 1993, The Journal of urology.
[150] P. Carroll,et al. The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. , 1993, The Journal of urology.
[151] Jun Nakashima,et al. Prognostic Implication of Microvascular Invasion in Biochemical Failure in Patients Treated with Radical Prostatectomy , 2003, Urologia Internationalis.
[152] M. Soloway,et al. Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion. , 2003, The Journal of urology.
[153] M. Banerjee,et al. Prognostic implications of a positive apical margin in radical prostatectomy specimens. , 1998, The Journal of urology.
[154] J W Moul,et al. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. , 1996, The Journal of urology.
[155] P. Russo,et al. Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors. , 1998, Urology.
[156] A. Renshaw,et al. Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice. , 1997, American journal of clinical pathology.
[157] D. Johnston,et al. A Streamlined Three-Dimensional Volume Estimation Method Accurately Classifies Prostate Tumors by Volume , 2003, The American journal of surgical pathology.
[158] D. Johnston,et al. Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. , 2002, The Journal of urology.
[159] J. Epstein,et al. Do close but negative margins in radical prostatectomy specimens increase the risk of postoperative progression? , 1997, The Journal of urology.
[160] S. Bigler,et al. Trends in diagnosis of stage T1a-b prostate cancer. , 1997, The Journal of urology.
[161] J. Moul,et al. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. , 1998, The Journal of urology.
[162] P. di Sant'Agnese,et al. Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma , 1998, The Prostate. Supplement.
[163] M. Benson,et al. Flow cytometric analysis of localized adenocarcinoma of the prostate: The use of archival DNA analysis in conjunction with pathological grading to predict clinical outcome following radical retropubic prostatectomy , 1990, The Prostate.
[164] D. Bostwick,et al. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. , 1997, Urology.
[165] A. Partin,et al. Extended followup of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular perforation. , 1996, The Journal of urology.
[166] D. Bostwick,et al. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma. , 1999, Urology.
[167] J. Moul,et al. Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer. , 1998, The Journal of urology.
[168] P. Humphrey,et al. Histologic Grade, DNA Ploidy, and Intraglandular Tumor Extent as Indicators of Tumor Progression of Clinical Stage B Prostatic Carcinoma: A Direct Comparison , 1991, The American journal of surgical pathology.
[169] T. Stamey,et al. The predictive significance of substaging stage A prostate cancer (A1 versus A2) for volume and grade of total cancer in the prostate. , 1992, The Journal of urology.
[170] A. Partin,et al. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. , 1994, The Journal of urology.
[171] J. Serth,et al. The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy. , 1998, European journal of cancer.
[172] L. Gomella,et al. Pathologic comparison of laparoscopic versus open radical retropubic prostatectomy specimens. , 2003, Urology.
[173] M. Rubin,et al. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31. , 2000, American journal of clinical pathology.
[174] Dogu Teber,et al. Laparoscopic versus open radical prostatectomy: a comparative study at a single institution. , 2003, The Journal of urology.
[175] C. Cordon-Cardo,et al. Inactivation of the p53 pathway in prostate cancer: impact on tumor progression. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[176] T. Stamey,et al. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. , 1989, The Journal of urology.
[177] H. Zincke,et al. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy. , 1995, Urology.
[178] M. Banerjee,et al. Should Gleason score 7 prostate cancer be considered a unique grade category? , 1999, Urology.
[179] J. Cheville,et al. Expression of p27kip1 in prostatic adenocarcinoma. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[180] N. Rioux-Leclercq,et al. Prediction of outcome after radical prostatectomy in men with organ-confined Gleason score 8 to 10 adenocarcinoma. , 2002, Urology.
[181] H. Neuwirth,et al. Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy. , 1995, The Journal of urology.
[182] R. Cornum,et al. Influence of surgical approach on cancer control following radical prostatectomy. , 1996, Urologic oncology.
[183] J. Schlesselman,et al. Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[184] F. Labrie,et al. Down-staging of early stage prostate cancer before radical prostatectomy: The first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonist , 1994 .
[185] M. Toublanc,et al. Radical prostatectomy for prostate cancer: the perineal approach increases the risk of surgically induced positive margins and capsular incisions. , 1998, The Journal of urology.
[186] D. Bostwick,et al. p53 Alteration in regional lymph node metastases from prostate carcinoma , 1999, Cancer.
[187] M. Rubin,et al. Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors. , 2000, Urology.
[188] J. Cheville,et al. Cancer volume of lymph node metastasis predicts progression in prostate cancer. , 1998, The American journal of surgical pathology.
[189] D. Wood,et al. Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer , 1995 .
[190] Victor Reuter,et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. , 2003, The Journal of urology.
[191] M. Terris,et al. Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database. , 2003, The Journal of urology.
[192] J. Oxley,et al. Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy. , 1999, The Journal of urology.
[193] F. Mostofi,et al. Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer. , 1996, The Journal of urology.
[194] A. Partin,et al. Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy. , 1996, Human pathology.
[195] M. Toublanc,et al. Predictive value of pathological features for progression after radical prostatectomy. , 1994, European urology.
[196] J. McNeal,et al. Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma. , 1996, The American journal of surgical pathology.
[197] J. McNeal. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. , 1992, Human pathology.
[198] L. Klotz,et al. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. , 1998, Cancer research.
[199] T. Stamey,et al. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. , 2002, Urology.
[200] T. Wheeler,et al. Heterogeneity of prostate cancer in radical prostatectomy specimens. , 1994, Urology.
[201] Rodolfo Montironi,et al. Handling and pathology reporting of radical prostatectomy specimens. , 2003, European urology.
[202] A. Partin,et al. Needle Biopsy of Recurrent Adenocarcinoma of the Prostate After Radical Prostatectomy , 2000, Modern Pathology.
[203] A. Partin,et al. Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease‐free survival among patients with prostate cancer , 1992, Cancer.
[204] D. Johnston,et al. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy , 2001, Cancer.
[205] D. Grignon,et al. Relationship of p21WAF1 expression with disease‐free survival and biochemical recurrence in prostate adenocarcinomas (PCa) , 1999, The Prostate.
[206] R K Babayan,et al. Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. , 1996, Urology.
[207] The Gleason Grading System: An Overview , 1999 .
[208] P. Scardino,et al. The Mechanisms and Prognostic Significance of Seminal Vesicle Involvement by Prostate Cancer , 1993, The American journal of surgical pathology.
[209] T. Stamey,et al. Capsular Penetration in Prostate Cancer. Significance for Natural History and Treatment , 1990, The American journal of surgical pathology.
[210] D. Bostwick,et al. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. , 1994, The Journal of urology.
[211] A. De la taille,et al. Prostate specimen reevaluation in patients with organ confined prostate cancer and postoperative biological recurrence. , 1996, The Journal of urology.
[212] J. Epstein. Evaluation of Radical Prostatectomy Capsular Margins of Resection: The Significance of Margins Designated as Negative, Closely Approaching, and Positive , 1990, American Journal of Surgical Pathology.
[213] D. Paulson,et al. Radical prostatectomy: the pros and cons of the perineal versus retropubic approach. , 1992, The Journal of urology.
[214] C. Amling,et al. Malignant cytological washings from prostate specimens: an independent predictor of biochemical progression after radical prostatectomy. , 2001, The Journal of urology.
[215] J. Epstein,et al. Increasing incidence of minimal residual cancer in radical prostatectomy specimens. , 1997, The American journal of surgical pathology.
[216] Jonathan A. Cooper,et al. Role of epidermal growth factor‐stimulated protein kinase in control of proliferation of A431 cells , 1982, Journal of cellular biochemistry.
[217] R. B. Smith,et al. Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. , 1992, The Journal of urology.
[218] C. Sheehan,et al. Prognostic factors in prostate cancer. , 2003, American journal of clinical pathology.
[219] A. Partin,et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. , 2001, The Urologic clinics of North America.
[220] A. Partin,et al. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease. , 1995, The Journal of urology.
[221] A W Partin,et al. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. , 1993, The Journal of urology.
[222] M E Hammond,et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.
[223] P. Scardino,et al. Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. , 1992, The Journal of urology.
[224] J. Ross,et al. Prognostic significance of HER‐2/neu gene amplification status by fluorescence in Situ hybridization of prostate carcinoma , 1997, Cancer.
[225] S. Groshen,et al. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. , 1998, Journal of the National Cancer Institute.